Publications by authors named "Matthieu Ponsoye"

Claim this Profile
I
Influenza-like illness in individuals treated with immunosuppressants, biologics, and/or systemic corticosteroids for autoimmune or chronic inflammatory disease: A crowdsourced cohort study, France, 2017-2018.
Ségolène Greffe, Caroline Guerrisi, Cécile Souty, Ana-Maria Vilcu, Gilles Hayem, Matthieu Ponsoye

Influenza Other Respir Viruses· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of severe renal disease in anti-neutrophil-cytoplasmic-antibody-associated vasculitis: the place of rituximab and plasma exchange?
Pauline Morel, Alexandre Karras, Raphaël Porcher, Xavier Belenfant, Vincent Audard, Matthieu Ponsoye

Rheumatology (Oxford)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis.
Mathilde Roumier, Romain Paule, Alexandre Vallée, Julien Rohmer, Marie Ballester, Matthieu Ponsoye

J Clin Immunol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vasculitis associated with myelodysplastic syndrome and chronic myelomonocytic leukemia: French multicenter case-control study.
Anne Laure Roupie, Alexis Guedon, Benjamin Terrier, Constance Lahuna, Vincent Jachiet, Matthieu Ponsoye

Semin Arthritis Rheum· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal Behcet's-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature review.
Nadege Wesner, Louis Drevon, Alexis Guedon, Jean Baptiste Fraison, Benjamin Terrier, Matthieu Ponsoye

Leuk Lymphoma· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory disorders associated with trisomy 8-myelodysplastic syndromes: French retrospective case-control study.
Nadege Wesner, Louis Drevon, Alexis Guedon, Jean Baptiste Fraison, Salim Trad, Matthieu Ponsoye

Eur J Haematol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis.
Matthieu Ponsoye, Camelia Frantz, Nadira Ruzehaji, Carole Nicco, Muriel Elhai

Ann Rheum Dis· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis.
Nadira Ruzehaji, Camelia Frantz, Matthieu Ponsoye, Jerome Avouac, Sonia Pezet

Ann Rheum Dis· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OX40L blockade protects against inflammation-driven fibrosis.
Muriel Elhai, Jérôme Avouac, Anna Maria Hoffmann-Vold, Nadira Ruzehaji, Olivia Amiar, Matthieu Ponsoye

Proc Natl Acad Sci U S A· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Kidney and thyroid dysfunction].
Matthieu Ponsoye, Romain Paule, Victor Gueutin, Gilbert Deray, Hassane Izzedine

Nephrol Ther· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis